Connect Sign In
Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status in settings such as schools or workplaces, but its role has changed as the pandemic has evolved.
The University of Utah, ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test.
ARUP’s Adam Barker, PhD, will be the featured presenter during the Dark Intelligence Group’s COVID-19 STAT Intelligence Briefing at 10 a.m. MDT on Tuesday, April 27.
Patricia Slev, PhD, ARUP Immunology Division section chief and University of Utah associate professor of pathology, is an author of newly published COVID-19 antibody testing guidelines.
The CDC has cited research in which the University of Utah’s HERO Project and ARUP Laboratories played a key role. The research is integral to new physical distancing guidelines.
Jonathan Genzen, MD, PhD, ARUP Laboratories’ chief operations officer, explains how the Johnson & Johnson SARS-CoV-2 vaccine works, and how it differs from the Moderna and Pfizer-BioNTech vaccines.
By the end of January, approximately 22–28% of Salt Lake County residents either had been infected with SARS-CoV-2 or had been vaccinated against the virus, according to the Utah HERO Project.
Diagnostic laboratory testing remains important for detecting active COVID-19 infection in vaccinated, partially vaccinated, and unvaccinated individuals.
Point-of-care antigen testing with the Abbott BinaxNOW COVID-19 Ag Card is not as sensitive as standard NAATs for detecting SARS-CoV-2 in asymptomatic college students, according to a study.
ARUP Laboratories announced that it is sequencing variants of SARS-CoV-2 in specimens positive for COVID-19 to enable detection of the more contagious “United Kingdom (UK) variant” of the virus.
